Showing results (1851-1860 of 2,593) with videos related to
Sort By:
Pageof 260
EFSA Journal. European Food Safety Authority|March 2, 2026
Safety assessment of the process Starlinger viscotec viscoZERO PET used to recycle post-consumer PET into food contact materials, Claude Lambré, Riccardo Crebelli, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 30, 2013
Selection of immunostimulant AS15 for active immunization with MAGE-A3 protein: results of a randomized phase II study of the European Organisation for Research and Treatment of Cancer Melanoma Group in Metastatic MelanomaWim H J Kruit, Stefan Suciu, Brigitte Dreno, et al.Virchows Archiv : an International Journal of Pathology|October 23, 2024
Reporting of somatic variants in clinical cancer care: recommendations of the Swiss Society of Molecular PathologyYann Christinat, Baptiste Hamelin, Ilaria Alborelli, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2023
Seven-Year Follow-Up of the Phase III KEYNOTE-006 Study: Pembrolizumab Versus Ipilimumab in Advanced MelanomaCaroline Robert, Matteo S Carlino, Catriona McNeil, et al.Journal of Medicinal Chemistry|January 25, 2024
MicroCycle: An Integrated and Automated Platform to Accelerate Drug DiscoveryCara E Brocklehurst, Eva Altmann, Corentin Bon, et al.International Journal of Cancer|September 28, 2002
The kinetics of the visible growth of a primary melanoma reflects the tumor aggressiveness and is an independent prognostic marker: a prospective studyJean Jacques Grob, Marie Aleth Richard, Johany Gouvernet, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 10, 2016
Prospective assessment of a gene signature potentially predictive of clinical benefit in metastatic melanoma patients following MAGE-A3 immunotherapeutic (PREDICT)P Saiag, R Gutzmer, P A Ascierto, et al.Bioorganic & Medicinal Chemistry Letters|September 23, 2011
Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13Ruben A Tommasi, Sven Weiler, Leslie W McQuire, et al.Human Pathology|October 7, 2008
Combined alpha-methylacyl coenzyme A racemase/p53 analysis to identify dysplasia in inflammatory bowel diseaseAndreas Marx, Timo Wandrey, Philipp Simon, et al.Acta Anaesthesiologica Scandinavica|July 2, 2024
The number of comorbidities as an important cofactor to ASA class in predicting postoperative outcome: An international multicentre cohort studyChristian A Grob, Luzius W Angehrn, Mark Kaufmann, et al.Pageof 260